Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Scientific Corp (NYSE:BSX)

26.18
Delayed Data
As of 4:02pm ET
 +0.21 / +0.81%
Today’s Change
19.67
Today|||52-Week Range
26.41
+21.04%
Year-to-Date
Boston Scientific (BSX) Misses on Q1 Earnings, Updates View
11:22am / Zacks.com - Paid Partner Content
Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead
Apr 24 / TheStreet.com - Paid Partner Content
Boston Scientific (BSX): Beats on Q1 Sales, Misses Earnings
8:52am / Zacks.com - Paid Partner Content
Will Boston Scientific (BSX) Surprise this Earnings Season?
Apr 21 / Zacks.com - Paid Partner Content
Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More
Apr 25 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close25.97
Today’s open25.97
Day’s range25.79 - 26.41
Volume12,027,348
Average volume (3 months)7,865,189
Market cap$35.6B
Dividend yield--
Data as of 4:02pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+12.20%
Earnings growth (next 5 years)+10.41%
Revenue growth (last year)+13.34%
P/E ratio104.7
Price/Sales3.55
Price/Book5.25

Competitors

 Today’s
change
Today’s
% change
BDXBecton Dickinson and...+2.74+1.52%
ZBHZimmer Biomet Holdin...-7.22-5.76%
BCRC R Bard Inc+2.13+0.70%
TFXTeleflex Inc+3.27+1.61%
Data as of 4:02pm ET, 04/27/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$0.31
Annual revenue (last year)$8.4B
Annual profit (last year)$347.0M
Net profit margin4.14%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael F. Mahoney
Executive Vice President-
Operations
Edward Mackey
Corporate headquarters
Marlborough, Massachusetts

Forecasts